Rhythmic Auditory Stimulaton Using Personalized Music Therapy in Parkinson's Disease
Trial
N/A
Recruiting
Jan. 29, 2026
Pilot Study of Robotic Spinal Mobilization in Parkinson's Disease
Trial
N/A
Not yet recruiting
Jan. 29, 2026
Adaptive vs. Continuous Subthalamic Nucleus Deep Brain Stimulation in Parkinson's Disease
Trial
N/A
Recruiting
Jan. 28, 2026
Effect of Melatonin on Oxidative Stress Parameters in Levodopa-Treated Parkinson's Disease Patients
Trial
Phase 2
Enrolling by invitation
Jan. 28, 2026
Anti-Diabetic Medications to Fight PD and LBD
Trial
Phase 4
Completed
Jan. 27, 2026
Effects of Exercise With Visual Feedback in Parkinson's Disease
Trial
N/A
Recruiting
Jan. 26, 2026
Facilitating Diagnostics and Prognostics of Parkinsonian Syndromes Using Neuroimaging
Trial
N/A
Recruiting
Jan. 26, 2026
Turkish Adaptation of "Parkinson's Disease Quality of Life 7 (PDQoL7)" Questionnaire
Trial
N/A
Completed
Jan. 26, 2026
Comparing Biomarker-Guided DBS Programming With Standard Clinical Monopolar Programming
Trial
N/A
Not yet recruiting
Jan. 26, 2026
Examination of Factors Associated With Fatigue in Individuals Diagnosed With Parkinson's Disease
Trial
N/A
Completed
Jan. 26, 2026
Effects of Pallidal Deep Brain Stimulation Location on Motor Impairment in Parkinson's Disease
Trial
N/A
Recruiting
Jan. 25, 2026
Circuit-Based Deep Brain Stimulation for Parkinson's Disease P1A2&3 Catalyst
Trial
N/A
Recruiting
Jan. 25, 2026
MR-guided Focused Ultrasound Plus GCase
Trial
N/A
Recruiting
Jan. 22, 2026
Parkin Mutations and Their Functional Consequences
Trial
N/A
Completed
Jan. 21, 2026
Fexofenadine as Adjuvant Therapy in Parkinson Disease
Trial
Phase 2
Recruiting
Jan. 20, 2026
Attributional Style and Parkinson's Disease
Trial
N/A
Completed
Jan. 20, 2026
GYKO-Based L-Test Reliability in Parkinson's Disease
Trial
N/A
Active, not recruiting
Jan. 20, 2026
Voice-activated Intelligent Personal Assistant (VIPA) Intervention for People With Parkinson's Disease
Trial
N/A
Completed
Jan. 20, 2026
A Study to Evaluate the Safety of Neural Stem Cells in Patients With Parkinson's Disease
Trial
Phase 1
Completed
Jan. 19, 2026